News Quantified

TMDX – transmedics group, inc. (US:NASDAQ)

Stock Stats

News Stats

Order Stats

News

TransMedics to Report Fourth Quarter and Full Year 2025 Financial Results on February 24, 2026

TransMedics Receives Full and Unconditional FDA IDE Approval for Next-Generation OCS Heart ENHANCE Trial

TransMedics Group, Inc. (TMDX): A Bull Case Theory [Yahoo! Finance]

TransMedics: Italian NOP Program Reinforces Huge International Opportunity [Seeking Alpha]

TransMedics Group (NASDAQ:TMDX) was downgraded by analysts at Wall Stree

2.1%

BEAT

10.2%

BEAT

16.1%

BEAT

3.6%

BEAT

Canaccord Genuity

Form 8-K TransMedics Group, Inc. For: Feb 01

Form 8-K TransMedics Group, Inc. For: Jan 08

Form 4 TransMedics Group, Inc. For: Dec 04 Filed by: Hernandez Gerardo

Form 4 TransMedics Group, Inc. For: Dec 03 Filed by: Weill David

Form 144 TransMedics Group, Inc. Filed by: Weill David

Top News Gainers

3/17 TransMedics Announces Temporary Postponement of OCS Heart FDA Advisory Panel Committee Meeting Due to COVID-19 Emergency 25.3%

3/2 TransMedics Group, Inc. (TMDX) Q4 2019 Earnings Call Transcript [The Motley Fool] 19.5%

4/13 Form 8-K TransMedics Group, Inc. For: Apr 10 12.4%

3/17 Form 10-K TransMedics Group, Inc. For: Dec 28 12.0%

11/1 2 Hot Healthcare IPOs [The Motley Fool] 10.0%

8/22 TransMedics Group Inc (NASDAQ: TMDX) was downgraded by analysts at Zacks Investment Research from a "hold" rating to a "sell" rating. 7.6%

7/17 TransMedics to Report Second Quarter 2019 Financial Results on August 7, 2019 6.9%

12/12 Form 4 TransMedics Group, Inc. For: Dec 12 Filed by: KANIA EDWIN M JR 6.7%

4/14 Form DEF 14A TransMedics Group, Inc. For: Jun 04 6.4%

4/7 TransMedics Group Inc (NASDAQ: TMDX) is now covered by analysts at Oppenheimer Holdings Inc.. They set a "buy" rating and a $25.00 price target on the stock. 4.7%

Top News Decliners

3/14 TransMedics Group Inc (NASDAQ: TMDX) was downgraded by analysts at BidaskClub from a "hold" rating to a "sell" rating. -18.2%

11/6 TransMedics Reports Third Quarter 2019 Financial Results -10.9%

3/6 Form 4 TransMedics Group, Inc. For: Feb 27 Filed by: DAMME LAURA -10.8%

3/27 TransMedics Group Inc (NASDAQ: TMDX) was downgraded by analysts at BidaskClub from a "hold" rating to a "sell" rating. -8.8%

4/14 TransMedics Group Inc (NASDAQ: TMDX) had its "buy" rating re-affirmed by analysts at Canaccord Genuity. They now have a $19.00 price target on the stock. -8.7%

8/7 TransMedics Reports Second Quarter 2019 Financial Results -6.2%

2/19 TransMedics to Report Fourth Quarter and Full Year 2019 Financial Results on March 2, 2020 -4.9%

3/20 TransMedics Group Inc (NASDAQ: TMDX) was upgraded by analysts at BidaskClub from a "sell" rating to a "hold" rating. -4.8%

2/28 Form 8-K TransMedics Group, Inc. For: Feb 27 -4.7%

5/6 Form 4 TransMedics Group, Inc. For: May 06 Filed by: Lung Biotechnology PBC -4.6%

Live Event: How Top Hedge Funds Use News To Make Money From The Stock Market & How Ordinary People Are Copying Their Strategies

If you could use the news to make money from the stock market, would you? Join us on our live online event where you’ll discover this simple scientific method that has allowed ordinary people get a huge return from the stock market without excessive risk.

Click Here To Register For The Live Online Workshop

In short, News Quantified specializes in matching financial news with market data. We've analyzed 10s of millions of news events and know exactly which ones have an outsized impact on stock prices. So every single time a news item is released we know exactly what the average effect will be on a particular stock.

Latest Posts

Trading the Google Earnings Announcement: A Strategic Preview

Earnings Week Wrap-up and Takeaways

Earnings Season: Q3 Review, Q4 Kickoff – Morgan Stanley, Bank of America, Goldman Sachs, Netflix

Guerrilla Learning Opportunity: Wealth365 Conference Featuring News Quantified Founder and Much More

The Smart Way to Ten Minutes Per Day